Results 11 to 20 of about 62,474 (297)

Association of neovascular age-related macular degeneration with migraine [PDF]

open access: yesScientific Reports, 2022
Patients with early onset vascular pathology have been reported to manifest neovascular age-related macular degeneration (AMD). While the blood vessels involved in pathogenesis of migraine remains controversial, it is generally accepted that a major ...
Tung-Mei Kuang   +4 more
doaj   +4 more sources

Pegaptanib for neovascular age-related macular degeneration [PDF]

open access: greenAmerican Journal of Ophthalmology, 2005
Pegaptanib, an anti-vascular endothelial growth factor therapy, was evaluated in the treatment of neovascular age-related macular degeneration.We conducted two concurrent, prospective, randomized, double-blind, multicenter, dose-ranging, controlled clinical trials using broad entry criteria.
E. S. Gragoudas   +4 more
openalex   +5 more sources

Radiation therapy for neovascular age-related macular degeneration

open access: yesClinical Ophthalmology, 2011
Robert Petrarca, Timothy L JacksonDepartment of Ophthalmology, King’s College Hospital NHS Foundation Trust, London, UKAbstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients ...
Robert Petrarca, Timothy L Jackson
doaj   +7 more sources

Radiotherapy for neovascular age-related macular degeneration [PDF]

open access: greenCochrane Database of Systematic Reviews, 2010
Radiotherapy has been proposed as a treatment to prevent new vessel growth in people with neovascular age-related macular degeneration (AMD).The aim of this review was to examine the effects of radiotherapy on neovascular AMD.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group ...
Jennifer Evans   +2 more
openalex   +6 more sources

Photodynamic therapy for neovascular age-related macular degeneration

open access: yesPhilippine Journal of Ophthalmology, 2005
Background: In neovascular age-related macular degeneration (ARMD) new vessels grow under the retina, distorting vision and leading to scarring. This is exacerbated if the blood vessels leak.
Richard P.L. Wormald, MA, MB, BCh, MSc, FRCS, FRCOphth   +3 more
doaj   +4 more sources

Radiotherapy for neovascular age-related macular degeneration [PDF]

open access: yesCochrane Database of Systematic Reviews, 2020
Radiotherapy has been proposed as a treatment for new vessel growth in people with neovascular age-related macular degeneration (AMD).To examine the effects of radiotherapy on neovascular AMD.We searched CENTRAL, MEDLINE, Embase, LILACS and three trials registers and checked references of included studies. We last searched the databases on 4 May 2020. 
Evans, Jennifer R.   +3 more
openaire   +6 more sources

Photodynamic therapy for neovascular age-related macular degeneration [PDF]

open access: yesCochrane Database of Systematic Reviews, 2003
In neovascular age-related macular degeneration, new vessels grow under the retina, distorting vision and leading to scarring. This is further exacerbated if the blood vessels leak. Photodynamic therapy, originally used in cancer treatment, has been investigated as a way to treat the neovascular membranes without affecting the retina.The aim of this ...
Katherine S Henshaw   +3 more
openaire   +10 more sources

Mass spectrometry in ocular drug research

open access: yesMass Spectrometry Reviews, EarlyView., 2023
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo   +6 more
wiley   +1 more source

Experimental Models in Neovascular Age Related Macular Degeneration [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Neovascular age-related macular degeneration (vAMD), characterized by the neo-vascularization of the retro-foveolar choroid, leads to blindness within few years. This disease depends on angiogenesis mediated by the vascular endothelial growth factor A (VEGF) and to inflammation.
Rastoin, Olivia   +2 more
openaire   +3 more sources

Predominantly hemorrhagic choroidal neovascular lesion from exsudative age-related macular degeneration treated with intravitreal ranibizumab therapy

open access: yesRevista Brasileira de Oftalmologia, 2013
The authors relate a predominantly hemorrhagic choroidal neovascular lesion from neovascular. Age-related macular degeneration patient case treated with intravitreal ranibizumab therapy.
Miguel Hage Amaro, Aaron Brock Holler
doaj   +1 more source

Home - About - Disclaimer - Privacy